Description: The investment seeks daily investment results, of 300% of the performance of the S&P Biotechnology Select Industry Index ("index"). The index is provided by S&P and includes domestic companies from the biotechnology industry. The fund normally creates long positions by investing at least 80% of its assets in the securities that comprise the index and/or financial instruments that provide leveraged and unleveraged exposure to the index. These financial instruments include: swap agreements; options on securities and indices; forward contracts; reverse repurchase agreements; ETFs; and other financial instruments. The fund is non-diversified.
Home Page: www.direxioninvestments.com/products/daily-sp-biotech-bull-3x-shares
LABU Technical AnalysisExchange: NYSE ARCA
Country: US
Currency: US Dollar ($)
Category: Trading--Leveraged Equity
| Asset Allocation | |||
|---|---|---|---|
| Asset Class | Long % | Short % | Net Assets |
| Stock US | 73.69 | 0.00 | 73.69 |
| Cash | 29.14 | 7.63 | 21.51 |
| Other | 2.80 | 0.00 | 2.80 |
| Stock non-US | 1.99 | 0.00 | 1.99 |
| Sector Weights | ||
|---|---|---|
| Sector | Equity % | Relative to Category |
| Healthcare | 100.00 | 12.09 |
| World Regions | ||
|---|---|---|
| Region | Equity % | Relative to Category |
| North America | 97.37 | 94.18 |
| Europe Developed | 2.35 | 1.76 |
| United Kingdom | 0.28 | 0.35 |
| Japan | 0.00 | 0.01 |
| Australasia | 0.00 | 0.19 |
| Asia Emerging | 0.00 | 2.04 |
| Latin America | 0.00 | 0.34 |
| Asia Developed | 0.00 | 1.00 |
| Europe Emerging | 0.00 | 0.03 |
| Africa/Middle East | 0.00 | 0.11 |